Rogalska, A.; Forma, E.; Bryś, M.; Śliwińska, A.; Marczak, A.
Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3). Int. J. Mol. Sci. 2018, 19, 2750.
https://doi.org/10.3390/ijms19092750
AMA Style
Rogalska A, Forma E, Bryś M, Śliwińska A, Marczak A.
Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3). International Journal of Molecular Sciences. 2018; 19(9):2750.
https://doi.org/10.3390/ijms19092750
Chicago/Turabian Style
Rogalska, Aneta, Ewa Forma, Magdalena Bryś, Agnieszka Śliwińska, and Agnieszka Marczak.
2018. "Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3)" International Journal of Molecular Sciences 19, no. 9: 2750.
https://doi.org/10.3390/ijms19092750
APA Style
Rogalska, A., Forma, E., Bryś, M., Śliwińska, A., & Marczak, A.
(2018). Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3). International Journal of Molecular Sciences, 19(9), 2750.
https://doi.org/10.3390/ijms19092750